Mike Kelliher - Jan 2, 2024 Form 4 Insider Report for CAPRICOR THERAPEUTICS, INC. (CAPR)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CAPR	Stock Option (Right to Buy)	Award	$0	+29.3K	$0.00	29.3K	Jan 2, 2024	Common Stock	29.3K	$5.12	Direct	F1
transaction	CAPR	Stock Option (Right to Buy)	Award	$0	+890	$0.00	890	Jan 2, 2024	Common Stock	890	$5.12	Direct	F2
transaction	CAPR	Stock Option (Right to Buy)	Award	$0	+4.73K	$0.00	4.73K	Jan 2, 2024	Common Stock	4.73K	$5.12	Direct	F3
transaction	CAPR	Stock Option (Right to Buy)	Award	$0	+30K	$0.00	30K	Jan 2, 2024	Common Stock	30K	$5.12	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares vest 1/12th of the first day of each month, commencing February 1, 2024, with the last month vesting on December 31, 2024, until the stock option becomes fully vested and exercisable. The award pertains to annual board service. The option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Issuer if the reporting person's service to the Issuer terminates prior to vesting.
F2	The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board committee service.
F3	The shares of the award are fully vested and exercisable as of January 2, 2024, the date of the grant. The award pertains to annual board service.
F4	The shares of the award are fully vested and exercisable as of April 1, 2024.